Related Experiment Video
Updated: Dec 26, 2025

Induction and Validation of Cellular Senescence in Primary Human Cells
Published on: June 20, 2018
The role of cellular senescence in ageing and endocrine disease
Sundeep Khosla1,2, Joshua N Farr3,4, Tamara Tchkonia3,4
1Division of Endocrinology, Mayo Clinic, Rochester, MN, USA. khosla.sundeep@mayo.edu.
Abstract:
With the ageing of the global population, interest is growing in the 'geroscience hypothesis', which posits that manipulation of fundamental ageing mechanisms will delay (in parallel) the appearance or severity of multiple chronic, non-communicable diseases, as these diseases share the same underlying risk factor - namely, ageing. In this context, cellular senescence has received considerable attention as a potential target in preventing or treating multiple age-related diseases and increasing healthspan. Here we review mechanisms of cellular senescence and approaches to target this pathway therapeutically using 'senolytic' drugs that kill senescent cells or inhibitors of the senescence-associated secretory phenotype (SASP). Furthermore, we highlight the evidence that cellular senescence has a causative role in multiple diseases associated with ageing. Finally, we focus on the role of cellular senescence in a number of endocrine diseases, including osteoporosis, metabolic syndrome and type 2 diabetes mellitus, as well as other endocrine conditions. Although much remains to be done, considerable preclinical evidence is now leading to the initiation of proof-of-concept clinical trials using senolytics for several endocrine and non-endocrine diseases.
Insights
Cellular senescence, a hallmark of aging, is a promising target for treating age-related diseases. Therapies like senolytics aim to clear senescent cells, showing potential in clinical trials for endocrine and other conditions.
Area of Science:
- Gerontology
- Cellular Biology
- Endocrinology
Background:
- The global population is aging, increasing the prevalence of chronic diseases.
- The geroscience hypothesis suggests targeting aging mechanisms can delay multiple diseases.
- Cellular senescence is a key aging mechanism implicated in age-related diseases.
Purpose of the Study:
- To review the mechanisms of cellular senescence.
- To discuss therapeutic strategies targeting cellular senescence, including senolytics and SASP inhibitors.
- To highlight the role of cellular senescence in endocrine diseases and its potential as a therapeutic target.
Main Methods:
- Review of scientific literature on cellular senescence mechanisms.
- Analysis of preclinical and clinical evidence for senolytic and SASP inhibitor therapies.
- Focus on the role of cellular senescence in osteoporosis, metabolic syndrome, and type 2 diabetes mellitus.
Main Results:
- Cellular senescence plays a causative role in multiple age-related diseases.
- Senolytic drugs and SASP inhibitors show therapeutic potential.
- Preclinical evidence supports senolytics for various endocrine and non-endocrine diseases.
Conclusions:
- Cellular senescence is a critical target for combating age-related diseases.
- Senolytics and SASP inhibitors represent promising therapeutic avenues.
- Early clinical trials are underway, indicating significant progress in translating senolytics research into practice.
More Related Videos
Related Concept Videos
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Replicative Cell Senescence
The Effect of Aging on Tissues
Endocrine Signaling
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
The Endocrine System

